HAL (France)open access
SALVOVAR: a pragmatic randomized phase III trial comparing the SALVage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic OVARian cancers
0, Ovarian neoplasms, Prognosis, Pragmatic clinical trial, 1, Antineoplastic combined chemotherapy protocols
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 257523
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.